loading
loading
OneSource Specialty Pharma shares jumped nearly 14% in Tuesday’s trade on October 27, hitting a three-week high of ₹1,589 apiece, as investors cheered the company’s September-quarter performance. The pharmaceutical company announced its Q2 results during market hours, reporting revenue of ₹516.2 crore, up 37% year-on-year (YoY) and 15% quarter-on-quarter (QoQ). This marked its third consecutive quarter of sequential growth, driven by new drug-device combination (DDC) capacity and the execution of master services agreements (MSAs), alongside 12 launches and growth across all businesses. In terms of operational performance, EBITDA rose 53% YoY and 32% QoQ to ₹163.3 crore. Operating leverage supported margin expansion, while the addition of new capacity provided a runway for further volume growth. Adjusted profit after tax (PAT), excluding exceptional items, stood at ₹93.7 crore, compared with ₹6.37 crore in the same period last year. This represents an increase of approximately 1,372% YoY. Commenting on the performance, Neeraj Sharma, CEO and Managing Director of OneSource Specialty Pharma Limited, said, “Q2 delivered strong sequential growth, led by new DDC capacity. With our second commercial cartridge line, H2 will see new launches and a significant ramp-up in commercial volumes.” “Biologics momentum remained strong, with yet another US biotech onboarded during the quarter. With additional capacity and partnerships, we are well set for the next phase of growth,” Sharma added. The company has maintained its FY28 guidance of $400 million in organic revenue and a steady-state EBITDA margin of 40%. In its investor presentation, OneSource said its DDC capacity is expected to triple by FY28 as two cartridge lines begin commercial operations and factory acceptance testing (FAT) for the third line is completed. The company also said its biologics platform is gaining momentum, supported by new customer wins and a robust pipeline of opportunities. OneSource Specialty Pharma shares have seen sharp volatility in October, swinging between gains and losses. The stock has risen around 4.5% so far this month, putting it on track for its biggest monthly gain in recent months. Since its listing in January 2025, the stock has witnessed considerable volatility, with no sustained directional trend. Gains recorded during some periods were subsequently erased in the following months. At around ₹1,598 apiece, the stock remains nearly 29% below its listing-era highs, while trading about 50% above its record low of ₹1,057 apiece. Disclaimer: We advise investors to check with certified experts before making any investment decisions. For about a decade, Livemint—News Desk has been a credible source for authentic and timely news, and well-researched analysis on national news, business, personal finance, corporates, politics and geopolitics. We bring the latest updates on all the listed companies on BSE and NSE, startups, mutual funds, Union ministries, geopolitics, and untapped human interest stories from around the world, helping our readers to stay informed on the latest developments around the globe. Our Coverage Areas 1. Companies: Comprehensive news and analysis on listed and unlisted companies, corporate announcements, corporate chatter, C-suite, business trends, hiring alerts, layoffs, work-life balance, world's top billionaires and richest and more. 2. Personal finance: Insights into mutual funds, small savings schemes like - PPF, SSY, post office savings scheme, stock to watch, personal loans, credit cards, top bank FDs, real estate, income tax and more. 3. Politics: Comprehensive coverage of general elections, state elections and bypolls, Lok Sabha, Vidhan Sabha, Parliament, PMO, PIB, finance ministry, home ministry, among other union ministries and government departments. 4. National News: From metro cities like Delhi, Mumbai, and e to untapped stories from rural India, we cover human interest, health, education, crime and courts, and law and order, among other areas of public interest. 5. Economy: In-depth analysis of India's macro and micro-economic indicators like- GDP, inflation, forex, fiscal deficit, current account deficit, interest rate cycle, economic recovery, RBI circulars, indirect taxes, GST, Insolvency and Bankruptcy imports, exports and everything that impacts Indian economy. 6. Geopolitics: Well-rounded and deeply researched coverage on US News, Oval Office European Union, Ukraine Russia War, middle-east crisis, royal families and global leaders like - Donald Trump, Vladimir Putin, Kim Jong Un, Xi Jinping and premiers of other leading economies in the world. Meet the Team 1. Gulam Jeelani, Political Affairs Editor 2. Sugam Singhal, Senior Assistant Editor 3. Chanchal, Assistant Editor 4. Sanchari Ghosh, Chief Content Producer 5. Pratik Prashant Mukane, Chief Content Producer 6. Sayantani Biswas, Chief Content Producer 7. Ravi Hari, Deputy Chief Content Producer 8. Garvit Bhirani, Deputy Chief Content Producer 9. Akriti Anand, Senior Content Producer 10. Jocelyn Felix Fernandes, Senior Content Producer 11. Swastika Das Sharma, Content Producer 12. Mausam Jha, Content Producer 13. Riya R Alex, Trainee Content Producer Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates. Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.
document fetched 2026-10-28 02:53 · canonical https://livemint.com/market/stock-market-news/onesource-specialty-pharma-shares-jump-14-after-q2-results-recover-50-from-recent-lows-11793115107385.html